Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
Circulation · 2024
DOI: 10.1161/circulationaha.123.067391 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Yongjian Lin. Beteiligte Einrichtung: Department of Gastrointestinal and Gland Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal and Gland Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Yongjian Lin
Zitieren
APA
Lin, Y. (2024). Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067391
Vancouver
Lin Y. Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067391
BibTeX
@article{Lin2024,
author = {Lin, Yongjian},
title = {Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.067391}
}
EUVIMED